
INM Technical Analysis Summary (NASDAQ)
Analyze INM on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerINM Technical Analysis Summary (NASDAQ)
InMed Pharmaceuticals Inc. (NASDAQ: INM) stock currently shows a bullish trend on the NASDAQ, supported by momentum and strong buying pressure.
Technical conditions suggest InMed Pharmaceuticals Inc. on the NASDAQ is awaiting a decisive move. Technical conditions suggest InMed Pharmaceuticals Inc. is consolidating, awaiting a decisive move.
RSI (14): 63.84
Stochastic %K: 78.13
Williams %R: -35.92
Rate of Change (ROC): 797.06
Takeaway:InMed Pharmaceuticals Inc. shows strong bullish momentum, with buyers firmly in control.
MACD: 3.63
ADX: 54.36
ATR (14): 2.01
CCI (14): 48.06
Takeaway:InMed Pharmaceuticals Inc. shows strong upward trend with solid momentum and healthy volatility.
Takeaway:InMed Pharmaceuticals Inc. trades closer to resistance, supported by stronger momentum within bands.
Takeaway:InMed Pharmaceuticals Inc. trades near the upper channel, signaling resistance and risk of pullback.
Overall Takeaway:INM shows mixed signals in money flow analysis.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
No significant bearish signals detected.
Overall Recommendation:Technical indicators for InMed Pharmaceuticals Inc. are mixed, suggesting a Hold or wait-and-see approach.